Welcome to our dedicated page for CHICAGO RIVET & MACHINE CO SEC filings (Ticker: CVR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Chicago Rivet & Machine Co. filings document governance and shareholder matters for an Illinois operating company in the fastener and assembly equipment industry. Its proxy materials cover the annual meeting agenda, director elections, shareholder voting matters and ratification of the independent registered public accounting firm.
The filing record also identifies the company’s board-nomination process, audit oversight items and formal shareholder-meeting procedures. These disclosures sit alongside the company’s public-company context as a manufacturer of rivets, cold-formed fasteners, screw machine products, automatic rivet setting machines and related assembly equipment.
Chicago Rivet & Machine Co investor John A. Morrissey reports beneficial ownership of 97,463 common shares, representing about 10.1% of the company’s outstanding stock. He holds sole voting and dispositive power over all of these shares, which were acquired using personal funds for investment purposes. The filing notes that he and the late Walter W. Morrissey previously may have been deemed a group, but he now disclaims any current group with that estate or any other person.
Morrissey states he has no present plans for corporate actions such as mergers, reorganizations, or control changes, but he may buy or sell shares in the future depending on price, market conditions, and the issuer’s prospects. Recent activity includes open-market purchases of 500 shares at $10.76 and 5,500 shares at $10.99 on December 10, 2025, and 17 shares at $12.75 and 1,000 shares at $13.86 on December 11, 2025.
Chicago Rivet & Machine Co. (CVR) filed its Q3 2025 10‑Q, showing a return to quarterly profitability while warning of substantial doubt about its ability to continue as a going concern. Q3 net sales were $7,360,284, up 5.6% year over year, and gross profit rose to $1,329,496 (up 91.3%). Net income was $67,572, or $0.07 per share.
For the nine months, net sales were $21,903,997 (down 4.3%), with an operating loss of $282,687 and net income of $73,615, aided by a $339,520 gain from the February sale of the Albia, Iowa facility (about $678,000 proceeds). Cash and equivalents were $1,682,919 with $500,000 borrowed under a new $3,000,000 credit agreement (revolver $2.5M, non‑revolver $0.5M) maturing on April 1, 2026; the company was in covenant compliance at quarter‑end.
Management cites declining revenues in prior periods, negative operating cash flow, and reduced liquidity as factors driving the going‑concern uncertainty. A previously disclosed material weakness in internal control over inventory valuation remains unresolved. Shares outstanding were 966,132 as of November 7, 2025.
Chicago Rivet & Machine Co. reported lower sales and mixed profitability for the quarter ended June 30, 2025. Net sales were $7,298,077, down 9.4% from $8,059,477 a year earlier; six‑month sales were $14,543,712, down 8.6% year over year. Gross profit for the quarter was $975,062 versus $1,415,446 in the prior year quarter, and the company recorded an operating loss of $417,431 for the quarter.
Net loss for the quarter was $394,980, or $0.41 per share; year‑to‑date net income was $6,042 versus a prior‑year loss of $555,863, helped by a one‑time gain of $339,520 from the sale of the Albia facility. Cash totaled $1,213,830, total assets were $23,640,332 and shareholders' equity was $19,980,526 at June 30, 2025.
The filing discloses substantial doubt about the company’s ability to continue as a going concern due to declining revenues and recurring operating losses. Management actions include a $3,000,000 credit facility (with $500,000 drawn), Albia sale proceeds of approximately $678,000, a $1,100,000 customer settlement payable through 2029 with $880,000 accrued at June 30, 2025, sales team additions, and remediation plans for a material weakness in inventory valuation controls.